Salesforce CEO Benioff logs routine Form 4; ownership still 22M+ shares
Rhea-AI Filing Summary
Salesforce, Inc. (CRM) – Form 4 filed 07/01/2025
Chair & CEO Marc Benioff reported several routine insider transactions:
- 06/30/2025: A gift/transfer of 505,000 shares from Marc Benioff Fund LLC to a beneficiary trust at $0.
- 07/01/2025: Exercised 2,250 stock options at $161.50 (cost basis) and immediately sold the same number of shares in three tranches—529, 1,124 and 597 shares—at volume-weighted prices ranging from $271.55–$273.34. All trades were executed automatically under a pre-arranged Rule 10b5-1 plan adopted 01/09/2025.
Following the transactions Benioff directly owns 11,864,178 shares, indirectly controls 10,000,000 shares through the Fund and 107,000 shares via a separate trust, plus 193,622 unexercised options. The option exercise–sale pair is cash-neutral and the combined share dispositions represent well under 0.2 % of his total equity position. Consequently, the filing is viewed as administrative (estate planning & liquidity management) with negligible impact on CRM’s float or governance control.
Positive
- None.
Negative
- None.
Insights
TL;DR: Minor gift & tiny 10b5-1 sales; no change to strategic ownership.
The disposition of 505 k shares was a non-monetary transfer to a family trust, indicating estate planning rather than bearish sentiment. The 2,250-share option exercise and matched sale simply monetise vested options (gross proceeds ≈ $612 k) and eliminate associated tax/strike costs. Benioff retains ≈ 22 M share exposure (direct, indirect & options) worth > $6 bn at current pricing, so governance influence remains intact. Given daily CRM volume of ~6 M shares, the market absorption should be seamless. Impact on valuation: neutral.
TL;DR: Administrative insider filing; control, alignment unchanged.
The transfer to a beneficiary trust and continued use of a disclosed 10b5-1 plan comply with best-practice transparency. No evidence of opportunistic timing or material reduction in insider stake. Benioff’s combined direct & indirect holdings still exceed 8 % of shares outstanding, preserving strong founder alignment. Filing raises no red-flag governance concerns and is categorised as routine.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-qualified Stock Option (Right to Buy) | 2,250 | $0.00 | -- |
| Exercise | Common Stock | 2,250 | $161.50 | $363K |
| Sale | Common Stock | 529 | $271.5524 | $144K |
| Sale | Common Stock | 1,124 | $272.4557 | $306K |
| Sale | Common Stock | 597 | $273.3358 | $163K |
| Gift | Common Stock | 505,000 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Represents transfer of Marc Benioff Fund LLC (the "Fund") interests to a trust for the benefit of the reporting person's beneficiaries. No funds were exchanged, and no sale of shares occurred in the transfer. Shares held in the Fund. Fund interests are held in the reporting person's name or in trust. As indicated by the checkbox above, this transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 9, 2025. Shares held in the reporting person's name or in the Marc R. Benioff Revocable Trust. Weighted average price. These shares were sold in multiple transactions at prices ranging from $270.9625 to $271.9500 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Weighted average price. These shares were sold in multiple transactions at prices ranging from $271.9600 to $272.9500 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Weighted average price. These shares were sold in multiple transactions at prices ranging from $272.9567 to $273.8097 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Option vests over four years at the rate of 25% on March 22, 2020, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.
